{"id":575,"date":"2022-12-20T04:32:18","date_gmt":"2022-12-20T04:32:18","guid":{"rendered":"https:\/\/blogs.rch.org.au\/clinicalguide\/?p=575"},"modified":"2022-12-21T04:34:56","modified_gmt":"2022-12-21T04:34:56","slug":"new-cpg-asthma-preventer-treatments-in-adolescents-12-years","status":"publish","type":"post","link":"https:\/\/blogs.rch.org.au\/clinicalguide\/new-cpg-asthma-preventer-treatments-in-adolescents-12-years\/","title":{"rendered":"New CPG: Asthma preventer treatments in adolescents 12 years+"},"content":{"rendered":"<p><span data-contrast=\"none\">The <\/span><a href=\"https:\/\/www.rch.org.au\/clinicalguide\/guideline_index\/Asthma_preventer_treatment_in_adolescents_12_years__\/\"><span data-contrast=\"none\">asthma preventer treatments in adolescents 12 years+ CPG<\/span><\/a><span data-contrast=\"none\"> is a new CPG developed by the CPG Committee and endorsed by the Paediatric Improvement Collaborative (Sept 2022). Key areas the CPG comprehensively covers are: initiating therapy using an anti-inflammatory reliever-based regimen (or traditional SABA and inhaled ICS); stepping up or down therapy; and an approach for asthma not responding to treatment. <\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">CPG key points:\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<ol>\n<li><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><span data-contrast=\"auto\">Any adolescent with asthma should be on a treatment regimen that includes an ICS. Prescribing SABA treatment (ie salbutamol) alone is no longer recommended<\/span><span data-ccp-props=\"{&quot;335559685&quot;:360}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">For most adolescents with asthma, treatment can be started with as-needed (reliever) combination of an ICS and a LABA<\/span><span data-ccp-props=\"{&quot;335559685&quot;:360}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">Adolescents well controlled on traditional treatment with SABA and inhaled ICS, should not be changed without consulting the adolescent\u2019s care team or a senior clinician<\/span><span data-ccp-props=\"{&quot;335559685&quot;:360}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">Treatment can be stepped up and down according to response. Never cease an adolescent\u2019s ICS completely<\/span><span data-ccp-props=\"{&quot;335559685&quot;:360}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">Always check inhaler technique, compliance and contributing factors before dose adjustment<\/span><span data-ccp-props=\"{&quot;335559685&quot;:360}\">\u00a0<\/span><\/li>\n<\/ol>\n<p><span data-contrast=\"none\">There are also two new asthma CPGs in development: pre-school wheeze and asthma for 5\u201312 years, as well as an update of the current acute asthma CPG. <\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The asthma preventer treatments in adolescents 12 years+ CPG is a new CPG developed by the CPG Committee and endorsed by the Paediatric Improvement Collaborative (Sept 2022). Key areas the CPG comprehensively covers are: initiating therapy using an anti-inflammatory reliever-based regimen (or traditional SABA and inhaled ICS); stepping up or down therapy; and an approach &hellip; <a href=\"https:\/\/blogs.rch.org.au\/clinicalguide\/new-cpg-asthma-preventer-treatments-in-adolescents-12-years\/\">Continued<\/a><\/p>\n","protected":false},"author":3942,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-575","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/posts\/575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/users\/3942"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/comments?post=575"}],"version-history":[{"count":1,"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/posts\/575\/revisions"}],"predecessor-version":[{"id":576,"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/posts\/575\/revisions\/576"}],"wp:attachment":[{"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/media?parent=575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/categories?post=575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.rch.org.au\/clinicalguide\/wp-json\/wp\/v2\/tags?post=575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}